IGC Announces Issuance of Second Patent for the Treatment of Alzheimer's Using THC - IGC Pharma, INC.

Press

Releases

September 21, 2022

IGC Announces Issuance of Second Patent for the Treatment of Alzheimer’s Using THC

Related Posts

IGC Pharma Announces Publication of Landmark Caregiver Book on Alzheimer’s Disease

December 2, 2025

IGC Pharma Leverages MINT-AD to Identify Socioeconomic Risk Factors Driving Alzheimer’s and Aging Trends

November 25, 2025

IGC Pharma Reports Accelerated Q2 Progress and Strengthened Financial Focus: CALMA Trial Passes 50% Enrollment Milestone, Strategic Divestiture Optimizes Capital

November 18, 2025

CEO Update

igc pharma

IGC Pharma, Inc. Form S-3 11-14-25

December 4, 2025

igc pharma

IGC Pharma, Inc. Form S-8 10-31-25

December 4, 2025